A Comprehensive Patent Review on β-cyclodextrin Cross-linked Nanosponges for Multiple Applications

Author(s): Sandip Pawar, Pravin Shende*

Journal Name: Recent Patents on Nanotechnology

Volume 14 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Currently, the most important challenge in the development of therapeutics and actives is their poor aqueous solubility and bioavailability.

Objective: The low aqueous solubility, poor pharmacokinetic properties, and bioavailability associated with novel actives manifest in numerous challenges in the formulation of conventional dosage forms like tablets, capsules, suspensions, emulsions, etc. Nanosponges are a novel class of drug delivery system capable of encapsulating or entrapping both lipophilic and hydrophilic drugs. Target-specific drug delivery and controlled drug release are the advantages offered by nanosponges which make them a promising anti-tumor drug delivery system.

Methods: Nanosponges are colloidal structures comprising solid nanoparticles with cavities and meshlike structures for encapsulation of wide varieties of substances like antineoplastic agents, proteins and peptides, volatile oils, genetic material, etc. The methods of preparation of β-cyclodextrin-based nanosponges include solvent evaporation method, emulsion solvent evaporation method, ultrasound-assisted synthesis, hyper cross-linked cyclodextrin and interfacial phenomenon method. A large variety of nanosponges- based formulations are available in the market and some formulations of prostavastin, brexin, glymesason, mena-gargle, etc. are under clinical trials.

Results: Nanosponges possess potential applications in target site-specific drug delivery to liver, spleen, and lungs. Due to the surface functionalization, nanosponges show broad applications in water purification, protein delivery, chemical sensors, detection of explosives, agriculture, etc. In the near future, nanosponges-based products will capture a huge market for commercialization due to their improved properties and advantages.

Conclusion: This review provides an account of the patents related to nanosponges (2006-2018) and covers the broad applications of β-cyclodextrin-based nanosponges, their roles in vaccine delivery, cancer therapy, fire engineering, water purification, etc.

Keywords: Protein delivery, agriculture, tumor therapy, metal nanosponge, water purification, fire engineering, mosquito repellant.

[1]
Singh D, Soni GC, Prajapati SK. Recent advances in nanosponges as drug delivery system: A review article. Eur J Pharm Med Res 2016; 3(10): 364-71.
[2]
Shende PK, Trotta F. New applications of cyclodextrin nanosponges. Paperback LAP LAMBERT Academic Publishing. 2014; pp. 1-84. ISBN 13:978-3-659-51101-1
[3]
Sukumaran CPS, Visakh PM, Santulli C. β-cyclodextrin nANOSPONGEs (NS) based Natural Rubber latex (NR) nanocomposite: tensile, thermal and morphological characterization. Malaysian Poly J 2015; 10(2): 75-82.
[4]
Shende PK, Trotta F, Gaud RS, Deshmukh K, Cavalli R, Biasizzo M. Influence of different techniques on formulation and comparative characterization of inclusion complexes of ASA with β- cyclodextrin and inclusion complexes of ASA with PMDA crosslinked β-cyclodextrin nanosponges. J Incl Phenom Macrocycl Chem 2012; 74(1-4): 447-54.
[http://dx.doi.org/10.1007/s10847-012-0140-x]
[5]
Shende PK, Gaud RS, Bakal R, Patil D. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrinbased nanosponges on solubility, in vitro release and stability studies. Colloids Surf B Biointerfaces 2015; 136: 105-10. [http://dx.doi.org/10.1016/j.colsurfb.2015.09.002]. [PMID: 26364091]. http://dx.doi.org/10.1016/j.colsurfb.2015.09.002 PMID: 26364091
[6]
Li M, Si L, Pan H, et al. Excipients enhance intestinal absorption of ganciclovir by P-gp inhibition: assessed in vitro by everted gut sac and in situ by improved intestinal perfusion. Int J Pharm 2011; 403(1-2): 37-45. [http://dx.doi.org/10.1016/j.ijpharm.2010.10.017]. [PMID: 20969937]. http://dx.doi.org/10.1016/j.ijpharm.2010.10.017 PMID: 20969937
[7]
Cavalli R, Trotta F, Tumiatti W. Cyclodextrin-based nanosponges for drug delivery. J Incl Phenom Macrocycl Chem 2006; 56(1-2): 209-13.
[http://dx.doi.org/10.1007/s10847-006-9085-2]
[8]
Shende P, Kulkarni YA, Gaud RS, et al. Acute and repeated dose toxicity studies of different β-cyclodextrin-based nanosponge formulations. J Pharm Sci 2015; 104(5): 1856-63. [http://dx.doi.org/10.1002/jps.24416]. [PMID: 25754724]. http://dx.doi.org/10.1002/jps.24416 PMID: 25754724
[9]
Tiwari H, Mahor A, Dixit ND, Kushwaha M. A review on nanosponges. World J Pharm Pharm Sci 2014; 3(11): 219-33.
[10]
Trotta F, Cavalli R, Tumiatti W. Ultrasound assisted synthesis of cyclodextrin based nanosponges. EP Patent 1786841A12007.
[11]
Selvamuthukumar S, Anandam S, Krishnamoorthy K, Rajappan M. Nanosponges: A novel class of drug delivery system-review. J Pharm Pharm Sci 2012; 15(1): 103-11.
[http://dx.doi.org/10.18433/J3K308] [PMID: 22365092]
[12]
Patel EK, Oswal RJ. Nanosponge and micro sponges: A novel drug delivery system. Int J Res Pharm Chem 2012; 2: 237-44.
[13]
Caldera F, Tannous M, Cavalli R, Zanetti M, Trotta F. Evolution of cyclodextrin nanosponges. Int J Pharm 2017; 531(2): 470-9.
[http://dx.doi.org/10.1016/j.ijpharm.2017.06.072] [PMID: 28645630]
[14]
Swaminathan S, Vavia P, Trotta F, et al. In vitro release modulation and conformational stabilization of a model protein by use of swellable nanosponges of β-cyclodextrin 2010; 68((1-2)): 183-91
[15]
Lala R, Thorat A, Gargote C. Current trends in β-cyclodextrin-based drug delivery systems. Int J Res Ayurveda Pharm 2011; 2: 1520-6.
[16]
Indira B, Santosh Bolisetti S, Reddy SM, Reddy NS. Ch. Samrat. Nanosponges: A new era in drug delivery. J Pharm Res 2012; 5(12): 5293-6.
[17]
Sherje AP, Dravyakar BR, Kadam D, Jadhav M. Cyclodextrin-based nanosponges: A critical review. Carbohydr Polym 2017; 173: 37-49.
[http://dx.doi.org/10.1016/j.carbpol.2017.05.086] [PMID: 28732878]
[18]
Patil TS, Nalawade NA, Kakade VK, Kale SN. Nanosponges: A novel targeted drug delivery for cancer treatment. Int J Adv Res Dev 2017; 2: 55-62.
[19]
Rahi N, Kumar K. Nanosponges: A new era of versatile drug delivery system. Univ J Pharm Res 2017; 2(3): 31-5.
[http://dx.doi.org/10.22270/ujpr.v2i3.RW4]
[20]
Sharma R, Walker RB, Pathak K. Evaluation of kinetics and mechanism of drug release from econazole nitrate nanosponge-loaded carbapol hydrogel. Ind J Pham Edu Res 2011; 45(1): 25-31.
[21]
Yong L, Ji-Huan H. Bubble electrospinning for mass production of nanofibers. Int J Nonlinear Sci Numer Simul 2007; 8(3): 393-6.
[22]
Tian D, He JH. Macromolecular electrospinning: Basic concept & preliminary experiment. Results in Phys 2018; 11: 740-2.
[http://dx.doi.org/10.1016/j.rinp.2018.10.042]
[23]
Tian D, He CH, He JH. Macromolecule orientation in nanofibers. Nanomaterials (Basel) 2018; 8(11): 918.
[http://dx.doi.org/10.3390/nano8110918] [PMID: 30405041]
[24]
Li XX, Tian D, He C-H, He J-H. A fractal modification of the surface coverage model for an electrochemical arsenic sensor. Electrochim Acta 2018.
[http://dx.doi.org/10.1016/j.electacta.2018.11.042]
[25]
Shende PK, Chapalkar R, Deshmukh K, Gaud RS. Physicochemical investigation of engineered nanosuspensions containing model drug, lansoprazole. J Dispers Sci Technol 2016; 37(4): 504-11.
[http://dx.doi.org/10.1080/01932691.2015.1046553]
[26]
Trotta F, Shende PK, Biasizzo M. Method for preparing dextrin nanosponges World Patent 2012147069Al2012.
[27]
Kun L. Nanoparticles, nanosponges, methods of synthesis, and methods of use US Patent 20170152439A12017.
[28]
Trotta F, Tumiatti V, Cavalli R, Roggero CM, Mognetti B, Berta GN. Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs World Patent 2009003656Al2009.
[29]
Dongjin C. Preparation method for graphene sponge reinforced nanofiber membrane CN Patent 108486862A. 2018.
[30]
Farrell D, Limaye SY, Subramanian S. Silicon nanosponge particles US Patent 7569202B2. 2006.
[31]
Xiaofang L, Qiang S. Licorice flavone nanosponge and preparation process thereof CN Patent 108703944A. 2018.
[32]
Muthusamy E, Katla S. Template free and polymer free metal nanosponge and a process thereof US Patent 20110014300A1. 2011.
[33]
Jiangwei W, Huimin G, Qin Y. Modification method of oleophilic and hydrophobic nanosponge CN Patent 104987528A. 2015.
[34]
Qiang Y, Yanna H, Sun L. Class of binary alloy Pt-Cu nanosponges CN Patent 108372315A. 2018.
[35]
Choi WI, Sahu A, Vilos C, et al. Bioinspired heparin nanosponge prepared by photo-crosslinking for controlled release of growth factors. Sci Rep 2017; 7(1): 14351.
[http://dx.doi.org/10.1038/s41598-017-14040-5] [PMID: 29084990]
[36]
Bastiancich C, Scutera S, Alotto D, et al. Cyclodextrin-based nanosponges as a nanotechnology strategy for imiquimod delivery in pathological scarring prevention and treatment. J Nanopharm Drug Deliv 2014; 2: 311-24.
[http://dx.doi.org/10.1166/jnd.2014.1071]
[37]
Deshmukh K, Tanwar YS, Sharma S, Shende P, Cavalli R. Functionalized nanosponges for controlled antibacterial and antihypocalcemic actions. Biomed Pharmacother 2016; 84: 485-94.
[http://dx.doi.org/10.1016/j.biopha.2016.09.017] [PMID: 27685792]
[38]
Gilardi G, Trotta F, Tumiatti V. Cyclodextrin nanosponges as a carrier for biocatalysts, and in the delivery and release of enzymes, proteins, vaccines and antibodies World Patent 2009149883Al. 2009.
[39]
Trotta F, Tumiatti V. Cross-linked polymers based on cyclodextrins for removing polluting agents US Patent 20050154198A1. 2005.
[40]
Yang P. Sleeve-type stainless steel nano sponge spiral filter CN Patent 204017486U. 2014.
[41]
Hongwei F, Meng L, Minghai L. Filter membrane material adhered with nanometer sponge adsorbing material and preparation method of filter membrane material CN Patent 108126529A. 2018.
[42]
Trotta F, Tumiatti V, Cavalli R. Ultrasound-assisted synthesis of cyclodextrin-based nanosponges World Patent 2006002814A1. 2006.
[43]
Xiaocun W, Dragon P. Nanosponges application and negative ions in the air in the air purification apparatus for processing and purification method combined fine particulate matter CN Patent 105180312B. 2017.
[44]
Creasey D, Guenther D. Detection of explosives using Raman spectroscopy with gold and silver nanosponge alloy US Patent 20170205352 A1. 2017.
[45]
Roggero C, Di Carlo S, Tumiatti V. Use of functionalized nanosponges for the growth, conservation, protection and disinfection of vegetable organisms World Patent 2013046165Al. 2013.
[46]
Seglie L, Martina K, Devecchi M, Roggero C, Trotta F, Scariot V. The effects of 1-MCP in cyclodextrin-based nanosponges to improve the vase life of Dianthus caryophyllus cut flowers. Postharvest Biol Technol 2011; 59: 200-5.
[http://dx.doi.org/10.1016/j.postharvbio.2010.08.012]
[47]
Zhiqiang X. High and coldNanosponge synergistic improving the sound absorbing property of silica aerogels interior paint CN Patent 104962139B. 2017.
[48]
Junjie N, Akihiro K, Chao W, Li J. Sulfur nanosponge cathode for lithium-sulfur battery and methods of manufacture thereof US Patent 20160190558A1. 2016.
[49]
Changhua W, Hongmin P, Gang S. Preparation method TiO2 (b) nanosponges CN Patent 104649319B. 2016.
[50]
Alonji J, Poskovic M, Frache A. Cyclodextrin nanosponges as novel green flame retardants for PP, LLDPE and PA6. Carbohydr Polym 2012; 88: 1387-94.
[http://dx.doi.org/10.1016/j.carbpol.2012.02.038]
[51]
Cecone C, Caldera F, Trotta F, Bracco P, Zanetti M. Controlled release of DEET loaded on fibrous mats from electrospun PMDA/ cyclodextrin polymer. Molecules 2018; 23(7): 1694.
[http://dx.doi.org/10.3390/molecules23071694] [PMID: 29997364]
[52]
Pawar S, Shende P, Trotta F. Diversity of β-cyclodextrin-based nanosponges for transformation of actives. Int J Pharm 2019; 565: 333-50.
[http://dx.doi.org/10.1016/j.ijpharm.2019.05.015] [PMID: 31082468]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 1
Year: 2020
Page: [75 - 89]
Pages: 15
DOI: 10.2174/1872210513666190603083930
Price: $65

Article Metrics

PDF: 21
HTML: 2
EPUB: 1
PRC: 2